approves

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), significantly improving access to diabetes treatment. Glucagon-like peptide-1 (GLP-1) receptor agonists are designed to …

Underlying technology A brief history of CGM CGM is a wearable technology that allows users to track their blood sugar levels in real time. Historically, people with type 1 or …